{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:24:52Z","timestamp":1787117092517,"version":"build-2736575974"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Platelet count fluctuations are common in patients with intracerebral hemorrhage (ICH), but the prognostic relevance of these fluctuations remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective multicenter cohort study using MIMIC-IV as the primary cohort and an independent Chinese cohort for external validation. Platelet count CV was calculated as the sample standard deviation divided by the mean of at least three observed, nonmissing platelet measurements obtained during the index hospitalization within 15\u202fdays before ICU admission. Missing measurement fields were excluded and were not treated as zero. Logistic regression, Cox models, restricted cubic splines, Kaplan\u2013Meier analyses, subgroup analyses, reclassification metrics, and sensitivity analyses were performed. Primary multivariable models additionally adjusted for platelet measurement count, and effect estimates were reported per 0.1-unit increase in CV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The primary cohort included 2,202 patients, of whom 294 died during the index hospitalization. After adjustment for clinical covariates and platelet measurement count, each 0.1-unit increase in platelet count CV was associated with in-hospital mortality (OR, 1.21; 95% CI, 1.07\u20131.38;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.003), 28-day mortality (HR, 1.14; 95% CI, 1.04\u20131.26;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.006), 90-day mortality (HR, 1.11; 95% CI, 1.02\u20131.21;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.014), and 360-day mortality (HR, 1.11; 95% CI, 1.02\u20131.20;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.016). Results were consistent in fixed-three-measurement and landmark sensitivity analyses. Adding platelet count CV produced modest reclassification improvement (continuous NRI, 0.209; 95% CI, 0.079\u20130.372; IDI, 0.007; 95% CI, 0.001\u20130.019). In the external cohort, platelet count CV was associated with 28-day mortality after multivariable adjustment (HR per 0.1-unit increase, 1.141; 95% CI, 1.007\u20131.292;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.042).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Higher pre-ICU platelet count CV was associated with mortality after adjustment for clinical covariates and platelet-monitoring frequency. The association was directionally reproduced in the external cohort, although the effect estimate was modest. Prospective studies with standardized platelet-sampling schedules are needed before clinical implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1868807","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:36:43Z","timestamp":1787114203000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Coefficient of variation of platelet count as a prognostic Indicator for intracerebral hemorrhage: findings from a multicenter cohort"],"prefix":"10.3389","volume":"17","author":[{"given":"Tao","family":"Ge","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The Affiliated Lihuili Hospital of Ningbo University","place":["Ningbo, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Affiliated Lihuili Hospital of Ningbo University","place":["Ningbo, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taotao","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Affiliated Lihuili Hospital of Ningbo University","place":["Ningbo, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dachang","family":"Qiu","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Qingdao University, Qingdao Medical College, Qingdao University","place":["Qingdao, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Affiliated Lihuili Hospital of Ningbo University","place":["Ningbo, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pandi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Affiliated Lihuili Hospital of Ningbo University","place":["Ningbo, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Affiliated Lihuili Hospital of Ningbo University","place":["Ningbo, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s13311-020-00902-w","article-title":"Advances in therapeutic approaches for spontaneous intracerebral hemorrhage","volume":"17","author":"Al-Kawaz","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"111153","DOI":"10.1016\/j.brainresbull.2024.111153","article-title":"Preclinical evaluation on human platelet lysate for the treatment of secondary injury following intracerebral hemorrhage","volume":"220","author":"Qiu","year":"2025","journal-title":"Brain Res Bull"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1529415","DOI":"10.3389\/fneur.2025.1529415","article-title":"Association between serum total bilirubin levels and 28-day all-cause mortality after intracerebral hemorrhage","volume":"16","author":"Qiu","year":"2025","journal-title":"Front Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/ijlh.12214","article-title":"Thrombocytopenia: an update","volume":"36","author":"Smock","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13613-025-01447-x","article-title":"Thrombocytopenia in the intensive care unit: diagnosis and management","volume":"15","author":"P\u00e8ne","year":"2025","journal-title":"Ann Intensive Care"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12883-020-01794-1","article-title":"Thrombocytopenia and platelet course on hospital mortality in neurological intensive care unit: a retrospective observational study from large database","volume":"20","author":"Zhou","year":"2020","journal-title":"BMC Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1007\/s00701-022-05277-9","article-title":"Early thrombocytopenia is associated with an increased risk of mortality in patients with traumatic brain injury treated in the intensive care unit: a Finnish intensive care consortium study","volume":"164","author":"Lillem\u00e4e","year":"2022","journal-title":"Acta Neurochir"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00134-023-07225-2","article-title":"Thrombocytopenia and platelet transfusions in ICU patients: an international inception cohort study (PLOT-ICU)","volume":"49","author":"Anthon","year":"2023","journal-title":"Intensive Care Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1429988","DOI":"10.3389\/fneur.2024.1429988","article-title":"Prognostic value of thrombocytopenia during hospitalizations in intracerebral hemorrhage patients","volume":"15","author":"Feng","year":"2024","journal-title":"Front Neurol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1161\/STROKEAHA.120.031478","article-title":"Thrombocytopenia and clinical outcomes in intracerebral hemorrhage: a retrospective multicenter cohort study","volume":"52","author":"Mrochen","year":"2021","journal-title":"Stroke"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1177\/17474930251392707","article-title":"Thrombocytopenia as a predictor of hematoma expansion and mortality in intracerebral hemorrhage","volume":"21","author":"Wilson","year":"2025","journal-title":"Int J Stroke"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jama.2025.7529","article-title":"Platelet transfusion: 2025 AABB and ICTMG international clinical practice guidelines","volume":"334","author":"Metcalf","year":"2025","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci Data"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e588","DOI":"10.1212\/NXI.0000000000000588","article-title":"Systemic inflammatory response syndrome and long-term outcome after intracerebral hemorrhage","volume":"6","author":"Hagen","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2147\/JIR.S394635","article-title":"Systemic inflammatory response syndrome on admission and clinical outcomes after intracerebral hemorrhage","volume":"16","author":"Liu","year":"2023","journal-title":"J Inflamm Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"12772","DOI":"10.3390\/ijms232112772","article-title":"Platelets and their role in hemostasis and thrombosis-from physiology to pathophysiology and therapeutic implications","volume":"23","author":"Scridon","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3390\/medicina58091311","article-title":"Molecular pathogenesis of endotheliopathy and endotheliopathic syndromes, leading to inflammation and microthrombosis, and various hemostatic clinical phenotypes based on \"two-activation theory of the endothelium\" and \"two-path unifying theory\" of hemostasis","volume":"58","author":"Chang","year":"2022","journal-title":"Medicina"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/ijs.12309","article-title":"European stroke organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage","volume":"9","author":"Steiner","year":"2014","journal-title":"Int J Stroke"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","article-title":"Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial","volume":"387","author":"Baharoglu","year":"2016","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s13054-019-2663-7","article-title":"The SOFA score-development, utility and challenges of accurate assessment in clinical trials","volume":"23","author":"Lambden","year":"2019","journal-title":"Crit Care"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1868807\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:36:51Z","timestamp":1787114211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1868807\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":20,"alternative-id":["10.3389\/fneur.2026.1868807"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1868807","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"article-number":"1868807"}}